Co-existence of Multiple Resistance Mechanisms in Clinical Isolates of Carbapenem-Resistant Pseudomonas Aeruginosa

dc.contributor.authorUskudar-Guclu, Aylin
dc.contributor.authorMirza, Hasan Cenk
dc.contributor.authorUnlu, Sezin
dc.contributor.orcIDhttps://orcid.org/0000-0002-1872-028Xen_US
dc.contributor.orcIDhttps://orcid.org/0000-0002-8853-3893en_US
dc.contributor.researcherIDAAU-6196-2020en_US
dc.contributor.researcherIDF-1232-2015en_US
dc.date.accessioned2022-12-12T07:29:42Z
dc.date.available2022-12-12T07:29:42Z
dc.date.issued2022
dc.description.abstractIntroduction: Multidrug resistance phenotype of Pseudomonas aeruginosa utilizes several resistant mechanisms to overcome the action of antibiotics. This phenotype is caused by several resistance mechanisms or a combination of thereof. This study aimed to evaluate various resistance mechanisms by phenotypic methods. Materials and Methods: Carbapenem-resistant P. aeruginosa were included in this study. Antimicrobial resistance mechanisms such as efflux pump activity, reduced outer membrane permeability (OMP), various beta-lactamase activities, and biofilm formation ability of clinical P aeruginosa isolates were determined by phenotypic methods. Results: Of the P aeruginosa isolates, 33.7% (n= 33/98) had a positive efflux pump activity. The co-existence of positive efflux pump activity and Metallo beta-lactamase (MBL) production was detected in 30.3% (10/33) of the isolates. In 34.7% of the clinical P. aeruginosa isolates, reduced OMP was detected and 70.6% of them were also biofilm producers. Totally 21.4% (21/98) of P aeruginosa isolates were evaluated as extended-spectrum beta-lactamase (ESBL) positive. AmpC beta-lactamase was detected in 15.3% (n= 15/98) of the clinical P. aeruginosa isolates. MBL activity was detected in 33.7% (n= 33/98) of the clinical P. aeruginosa isolates. Of the MBL-positive isolates, 69.7% were biofilm producers. The co-existence of MBL and reduced OMP was detected in 36.4% (n= 12/33). Conclusion: High resistance of P. aeruginosa was attributed to several resistance mechanisms or a combination of thereof. This infections caused by multidrug-resistant (MDR) P. aeruginosa are difficult to treat due to the co-existence of different resistance mechanisms.en_US
dc.identifier.endpage54en_US
dc.identifier.issue1en_US
dc.identifier.startpage45en_US
dc.identifier.urihttp://floradergisi.org/managete/fu_folder/2022-01/45-54%20Aylin%20Uskudar%20Guclu.pdf
dc.identifier.urihttp://hdl.handle.net/11727/8247
dc.identifier.volume27en_US
dc.identifier.wos000791588600006en_US
dc.language.isoengen_US
dc.relation.isversionof10.5578/flora.20229905en_US
dc.relation.journalFLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISIen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectP. aeruginosaen_US
dc.subjectBiofilmen_US
dc.subjectAntimicrobial resistance mechanismsen_US
dc.subjectCarbapenem resistanceen_US
dc.titleCo-existence of Multiple Resistance Mechanisms in Clinical Isolates of Carbapenem-Resistant Pseudomonas Aeruginosaen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
84.pdf
Size:
424.5 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: